Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)

Compare
6.99
0.00
(0.00%)
As of 12:45:39 PM GMT+8. Market Open.
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
8,343,000.87
7,963,958.57
6,567,198.58
4,287,726.75
2,761,682.04
Cost of Revenue
5,016,577.67
4,715,319.08
3,667,398.04
2,065,434.90
1,050,123.13
Gross Profit
3,326,423.20
3,248,639.49
2,899,800.54
2,222,291.85
1,711,558.91
Operating Expense
969,801.73
898,702.73
861,368.96
726,977.66
625,042.08
Operating Income
2,356,621.47
2,349,936.75
2,038,431.58
1,495,314.19
1,086,516.82
Net Non Operating Interest Income Expense
148,050.90
134,922.05
98,073.32
54,210.36
43,455.84
Pretax Income
2,260,444
2,204,084.48
2,273,607.69
1,539,036.13
1,477,234.62
Tax Provision
430,115.36
426,651.26
400,609.84
250,088.52
158,644.26
Net Income Common Stockholders
1,829,678.99
1,779,476.93
1,880,090.07
1,294,510.05
1,323,711.06
Basic EPS
0.28
0.27
0.28
0.19
0.21
Diluted EPS
0.28
0.27
0.28
0.19
0.21
Basic Average Shares
6,526,427.54
6,590,655.30
6,714,607.38
6,813,210.79
6,303,385.98
Diluted Average Shares
6,526,427.54
6,590,655.30
6,714,607.38
6,813,210.79
6,303,385.98
Total Operating Income as Reported
2,370,955.21
2,225,323.16
2,278,988.47
1,554,573.88
1,501,807.63
Total Expenses
5,986,379.40
5,614,021.81
4,528,767
2,792,412.56
1,675,165.22
Net Income from Continuing & Discontinued Operation
1,829,678.99
1,779,476.93
1,880,090.07
1,294,510.05
1,323,711.06
Normalized Income
1,892,747.71
1,829,774.09
2,055,631.75
1,643,637.93
1,478,540.06
Interest Income
123,919.12
135,379.93
98,306.18
55,421.26
44,114.78
Interest Expense
96.61
119.75
--
442.41
376.16
Net Interest Income
148,050.90
134,922.05
98,073.32
54,210.36
43,455.84
EBIT
2,260,540.61
2,204,204.23
2,273,607.69
1,539,478.54
1,477,610.78
EBITDA
2,260,540.61
2,367,203.94
2,458,583.68
1,698,746.22
1,630,370.12
Reconciled Cost of Revenue
5,016,577.67
4,715,319.08
3,667,398.04
2,065,434.90
1,050,123.13
Reconciled Depreciation
--
162,999.72
184,975.99
159,267.68
152,759.34
Net Income from Continuing Operation Net Minority Interest
1,829,678.99
1,779,476.93
1,880,090.07
1,294,510.05
1,323,711.06
Total Unusual Items Excluding Goodwill
-77,889.46
-62,370.39
-213,087.77
-416,867.54
-173,457.03
Total Unusual Items
-77,889.46
-62,370.39
-213,087.77
-416,867.54
-173,457.03
Normalized EBITDA
2,338,430.06
2,429,574.33
2,671,671.45
2,115,613.76
1,803,827.15
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-14,820.74
-12,073.22
-37,546.08
-67,739.66
-18,628.02
12/31/2020 - 6/11/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade